Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg19_v2_chr6_-_144329531_144329546 | 0.67 | 2.5e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106114739 | 5.66 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr11_-_64511789 | 5.56 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr22_+_45898712 | 5.47 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
chr21_+_47518011 | 5.20 |
ENST00000300527.4
ENST00000357838.4 ENST00000310645.5 |
COL6A2
|
collagen, type VI, alpha 2 |
chr16_+_28943260 | 4.99 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr14_-_106237742 | 4.79 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr22_+_19744226 | 4.61 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
chr16_+_1306060 | 4.49 |
ENST00000397534.2
|
TPSD1
|
tryptase delta 1 |
chr5_-_168727786 | 4.46 |
ENST00000332966.8
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr5_-_168727713 | 4.36 |
ENST00000404867.3
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr14_-_106209368 | 4.21 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr15_-_79103757 | 4.14 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
chr16_+_226658 | 4.09 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chrX_+_118892545 | 4.07 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
chr14_+_102027688 | 4.06 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chrX_-_153881842 | 3.92 |
ENST00000369585.3
ENST00000247306.4 |
CTAG2
|
cancer/testis antigen 2 |
chr14_-_106312010 | 3.85 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr7_-_100171270 | 3.83 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
chr9_+_130478345 | 3.74 |
ENST00000373289.3
ENST00000393748.4 |
TTC16
|
tetratricopeptide repeat domain 16 |
chr14_-_106111127 | 3.62 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr14_-_106331652 | 3.62 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
chr12_-_48213568 | 3.56 |
ENST00000080059.7
ENST00000354334.3 ENST00000430670.1 ENST00000552960.1 ENST00000440293.1 |
HDAC7
|
histone deacetylase 7 |
chr13_+_110959598 | 3.53 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr22_+_23264766 | 3.52 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr12_+_50355647 | 3.51 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr16_+_1290694 | 3.48 |
ENST00000338844.3
|
TPSAB1
|
tryptase alpha/beta 1 |
chr12_+_52445191 | 3.45 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr1_+_16084428 | 3.45 |
ENST00000510929.1
ENST00000502638.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr3_-_158450475 | 3.36 |
ENST00000237696.5
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr7_-_19157248 | 3.33 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
chr7_+_44143925 | 3.23 |
ENST00000223357.3
|
AEBP1
|
AE binding protein 1 |
chr14_-_106478603 | 3.22 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr16_-_49890016 | 3.19 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr1_+_2160134 | 3.16 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr16_+_1291240 | 3.15 |
ENST00000561736.1
|
TPSAB1
|
tryptase alpha/beta 1 |
chr7_-_27169801 | 3.10 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chr15_+_101420028 | 3.06 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
chr14_-_106092403 | 3.05 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr8_+_99956662 | 3.05 |
ENST00000523368.1
ENST00000297565.4 ENST00000435298.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr20_+_42295745 | 3.03 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr14_-_106758101 | 3.02 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr10_-_125651258 | 3.01 |
ENST00000241305.3
|
CPXM2
|
carboxypeptidase X (M14 family), member 2 |
chr16_+_1290725 | 3.00 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
chr8_+_99956759 | 2.99 |
ENST00000522510.1
ENST00000457907.2 |
OSR2
|
odd-skipped related transciption factor 2 |
chr11_-_64512273 | 2.97 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr1_-_17307173 | 2.95 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr5_+_149546334 | 2.94 |
ENST00000231656.8
|
CDX1
|
caudal type homeobox 1 |
chr22_+_22453093 | 2.93 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr11_+_46402744 | 2.90 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr3_-_71834318 | 2.90 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr3_-_158450231 | 2.89 |
ENST00000479756.1
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr1_-_1293904 | 2.86 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr11_+_66624527 | 2.83 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr1_+_1109272 | 2.82 |
ENST00000379290.1
ENST00000379289.1 |
TTLL10
|
tubulin tyrosine ligase-like family, member 10 |
chr20_+_2795626 | 2.82 |
ENST00000603872.1
ENST00000380589.4 |
C20orf141
|
chromosome 20 open reading frame 141 |
chr19_+_49838653 | 2.81 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr8_-_57359131 | 2.81 |
ENST00000518974.1
ENST00000523051.1 ENST00000518770.1 ENST00000451791.2 |
PENK
|
proenkephalin |
chr15_+_81071684 | 2.80 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
chr21_+_47518695 | 2.79 |
ENST00000436769.1
|
COL6A2
|
collagen, type VI, alpha 2 |
chr22_+_22385332 | 2.75 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr3_-_185542817 | 2.74 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_185542761 | 2.73 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_+_74833518 | 2.73 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr19_+_55888186 | 2.70 |
ENST00000291934.3
|
TMEM190
|
transmembrane protein 190 |
chr16_+_811073 | 2.66 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
chr9_-_127269661 | 2.66 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr5_-_168728103 | 2.64 |
ENST00000519560.1
|
SLIT3
|
slit homolog 3 (Drosophila) |
chr6_+_168841817 | 2.64 |
ENST00000356284.2
ENST00000354536.5 |
SMOC2
|
SPARC related modular calcium binding 2 |
chr22_+_24115000 | 2.53 |
ENST00000215743.3
|
MMP11
|
matrix metallopeptidase 11 (stromelysin 3) |
chr17_-_6735012 | 2.53 |
ENST00000535086.1
|
TEKT1
|
tektin 1 |
chr1_-_1141927 | 2.50 |
ENST00000328596.6
ENST00000379265.5 |
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr16_+_2880157 | 2.49 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
chr2_+_239756671 | 2.49 |
ENST00000448943.2
|
TWIST2
|
twist family bHLH transcription factor 2 |
chr22_+_23237555 | 2.49 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr14_-_106322288 | 2.48 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr14_-_91884115 | 2.47 |
ENST00000389857.6
|
CCDC88C
|
coiled-coil domain containing 88C |
chr17_+_77751931 | 2.46 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
chr5_+_1008910 | 2.46 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
chr14_-_75078725 | 2.45 |
ENST00000556690.1
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr17_-_6735035 | 2.44 |
ENST00000338694.2
|
TEKT1
|
tektin 1 |
chr14_-_75079026 | 2.41 |
ENST00000261978.4
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
chr22_+_23248512 | 2.41 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr21_-_36262032 | 2.41 |
ENST00000325074.5
ENST00000399237.2 |
RUNX1
|
runt-related transcription factor 1 |
chr8_+_37654693 | 2.39 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
chr15_-_89438742 | 2.39 |
ENST00000562281.1
ENST00000562889.1 ENST00000359595.3 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
chr20_+_2795609 | 2.39 |
ENST00000554164.1
ENST00000380593.4 |
TMEM239
TMEM239
|
transmembrane protein 239 CDNA FLJ26142 fis, clone TST04526; Transmembrane protein 239; Uncharacterized protein |
chr15_-_65360276 | 2.36 |
ENST00000421977.3
|
RASL12
|
RAS-like, family 12 |
chrX_+_153813407 | 2.36 |
ENST00000443287.2
ENST00000333128.3 |
CTAG1A
|
cancer/testis antigen 1A |
chr2_-_1748214 | 2.34 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr2_+_42275153 | 2.34 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
chr14_-_107035208 | 2.33 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr14_-_106330824 | 2.32 |
ENST00000463911.1
|
IGHJ3
|
immunoglobulin heavy joining 3 |
chr14_-_106331447 | 2.32 |
ENST00000390564.2
|
IGHJ2
|
immunoglobulin heavy joining 2 |
chr14_-_106174960 | 2.31 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr16_+_2880369 | 2.30 |
ENST00000572863.1
|
ZG16B
|
zymogen granule protein 16B |
chr14_-_96180435 | 2.30 |
ENST00000556450.1
ENST00000555202.1 ENST00000554012.1 ENST00000402399.1 |
TCL1A
|
T-cell leukemia/lymphoma 1A |
chr22_+_23114284 | 2.29 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr11_-_6341724 | 2.27 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr16_+_71392616 | 2.27 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
chrX_+_153170455 | 2.26 |
ENST00000430697.1
ENST00000337474.5 ENST00000370049.1 |
AVPR2
|
arginine vasopressin receptor 2 |
chr12_-_48213735 | 2.26 |
ENST00000417902.1
ENST00000417107.1 |
HDAC7
|
histone deacetylase 7 |
chr16_+_1306093 | 2.25 |
ENST00000211076.3
|
TPSD1
|
tryptase delta 1 |
chr22_+_22764088 | 2.23 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr22_+_23134974 | 2.23 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_-_51071302 | 2.21 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
chr11_+_46402297 | 2.21 |
ENST00000405308.2
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr22_-_42322795 | 2.20 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
chr17_-_80291818 | 2.19 |
ENST00000269389.3
ENST00000581691.1 |
SECTM1
|
secreted and transmembrane 1 |
chr1_-_25256368 | 2.19 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr1_+_19970657 | 2.18 |
ENST00000375136.3
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr1_+_16085244 | 2.18 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr14_-_105635090 | 2.16 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr16_+_222846 | 2.16 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr11_+_842808 | 2.16 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr19_+_45251804 | 2.16 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
chr11_+_1891380 | 2.15 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
chr1_-_1142067 | 2.14 |
ENST00000379268.2
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr19_-_18902106 | 2.14 |
ENST00000542601.2
ENST00000425807.1 ENST00000222271.2 |
COMP
|
cartilage oligomeric matrix protein |
chr14_-_107211459 | 2.13 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr14_-_91884150 | 2.13 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
chr7_-_150675372 | 2.12 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr15_-_65360450 | 2.12 |
ENST00000220062.4
|
RASL12
|
RAS-like, family 12 |
chr10_+_104155450 | 2.11 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr2_-_25142708 | 2.11 |
ENST00000260600.5
ENST00000435135.1 |
ADCY3
|
adenylate cyclase 3 |
chr18_+_77160282 | 2.11 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr1_+_1567474 | 2.10 |
ENST00000356026.5
|
MMP23B
|
matrix metallopeptidase 23B |
chr3_-_27763803 | 2.10 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
chr1_+_1115056 | 2.10 |
ENST00000379288.3
|
TTLL10
|
tubulin tyrosine ligase-like family, member 10 |
chr19_-_7766991 | 2.09 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr10_-_131762105 | 2.09 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr17_-_41738931 | 2.08 |
ENST00000329168.3
ENST00000549132.1 |
MEOX1
|
mesenchyme homeobox 1 |
chr2_+_176981307 | 2.08 |
ENST00000249501.4
|
HOXD10
|
homeobox D10 |
chr4_+_3768075 | 2.07 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr19_+_8943074 | 2.07 |
ENST00000595891.1
|
MBD3L1
|
methyl-CpG binding domain protein 3-like 1 |
chr3_+_13610216 | 2.07 |
ENST00000492059.1
|
FBLN2
|
fibulin 2 |
chr22_+_23243156 | 2.07 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr22_+_23229960 | 2.06 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr7_+_72742178 | 2.06 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
chr19_+_41107249 | 2.05 |
ENST00000396819.3
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr17_-_3819751 | 2.05 |
ENST00000225538.3
|
P2RX1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
chr10_+_112836779 | 2.05 |
ENST00000280155.2
|
ADRA2A
|
adrenoceptor alpha 2A |
chr17_+_1182948 | 2.05 |
ENST00000333813.3
|
TUSC5
|
tumor suppressor candidate 5 |
chr5_-_180018540 | 2.05 |
ENST00000292641.3
|
SCGB3A1
|
secretoglobin, family 3A, member 1 |
chr6_+_130686856 | 2.04 |
ENST00000296978.3
|
TMEM200A
|
transmembrane protein 200A |
chr22_+_39853258 | 2.04 |
ENST00000341184.6
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
chr17_-_8648105 | 2.04 |
ENST00000539522.2
ENST00000293845.3 |
CCDC42
|
coiled-coil domain containing 42 |
chr11_+_46402482 | 2.04 |
ENST00000441869.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr19_+_16254488 | 2.02 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chrX_-_17878827 | 2.02 |
ENST00000360011.1
|
RAI2
|
retinoic acid induced 2 |
chr2_+_121493717 | 2.02 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
chr22_-_20792089 | 2.01 |
ENST00000405555.3
ENST00000266214.5 |
SCARF2
|
scavenger receptor class F, member 2 |
chr20_+_30458431 | 2.00 |
ENST00000375938.4
ENST00000535842.1 ENST00000310998.4 ENST00000375921.2 |
TTLL9
|
tubulin tyrosine ligase-like family, member 9 |
chr20_+_43343886 | 2.00 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr20_-_43438912 | 1.98 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
chr3_-_71834207 | 1.98 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
chr13_-_110959478 | 1.98 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr2_+_177053307 | 1.95 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
chr19_+_1026566 | 1.95 |
ENST00000348419.3
ENST00000565096.2 ENST00000562958.2 ENST00000562075.2 ENST00000607102.1 |
CNN2
|
calponin 2 |
chr1_+_16085263 | 1.94 |
ENST00000483633.2
ENST00000502739.1 ENST00000431771.2 |
FBLIM1
|
filamin binding LIM protein 1 |
chr22_+_22676808 | 1.94 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr3_-_128207349 | 1.94 |
ENST00000487848.1
|
GATA2
|
GATA binding protein 2 |
chr19_+_16435625 | 1.94 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr2_-_89442621 | 1.91 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr19_+_11651942 | 1.91 |
ENST00000587087.1
|
CNN1
|
calponin 1, basic, smooth muscle |
chr19_-_42927251 | 1.90 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr20_+_35201993 | 1.90 |
ENST00000373872.4
|
TGIF2
|
TGFB-induced factor homeobox 2 |
chr19_+_751122 | 1.90 |
ENST00000215582.6
|
MISP
|
mitotic spindle positioning |
chr7_+_331201 | 1.90 |
ENST00000510017.1
|
WI2-2373I1.2
|
WI2-2373I1.2 |
chr17_+_59529743 | 1.89 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
chr19_+_859654 | 1.89 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr11_-_68780824 | 1.89 |
ENST00000441623.1
ENST00000309099.6 |
MRGPRF
|
MAS-related GPR, member F |
chr1_-_32801825 | 1.88 |
ENST00000329421.7
|
MARCKSL1
|
MARCKS-like 1 |
chr9_+_139863695 | 1.88 |
ENST00000371629.1
|
C9orf141
|
chromosome 9 open reading frame 141 |
chr11_-_45928830 | 1.88 |
ENST00000449465.1
|
C11orf94
|
chromosome 11 open reading frame 94 |
chr10_+_88728189 | 1.88 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr17_-_73839792 | 1.88 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
chr14_-_106878083 | 1.88 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr20_-_3662666 | 1.88 |
ENST00000350009.2
|
ADAM33
|
ADAM metallopeptidase domain 33 |
chr1_-_17304771 | 1.87 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chrX_-_101771645 | 1.87 |
ENST00000289373.4
|
TMSB15A
|
thymosin beta 15a |
chr19_-_1652575 | 1.86 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
chr20_-_3662866 | 1.86 |
ENST00000356518.2
ENST00000379861.4 |
ADAM33
|
ADAM metallopeptidase domain 33 |
chr12_+_58005204 | 1.86 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr20_+_43343517 | 1.86 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr16_+_2867228 | 1.86 |
ENST00000005995.3
ENST00000574813.1 |
PRSS21
|
protease, serine, 21 (testisin) |
chr16_+_66638616 | 1.85 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr11_+_46402583 | 1.85 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr2_+_219745020 | 1.84 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr5_+_131593364 | 1.84 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr18_+_77155942 | 1.84 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr22_+_23063100 | 1.84 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr1_+_1567546 | 1.83 |
ENST00000378675.3
|
MMP23B
|
matrix metallopeptidase 23B |
chr12_+_54393880 | 1.83 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chr7_-_38370536 | 1.82 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr19_+_33210645 | 1.82 |
ENST00000444215.2
|
TDRD12
|
tudor domain containing 12 |
chr9_-_129885010 | 1.82 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chr16_-_15149917 | 1.82 |
ENST00000287706.3
|
NTAN1
|
N-terminal asparagine amidase |
chr16_-_89268070 | 1.81 |
ENST00000562855.2
|
SLC22A31
|
solute carrier family 22, member 31 |
chr14_-_106781017 | 1.81 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr1_-_159869912 | 1.81 |
ENST00000368099.4
|
CCDC19
|
coiled-coil domain containing 19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
2.0 | 12.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.0 | 12.1 | GO:0030421 | defecation(GO:0030421) |
1.4 | 4.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.4 | 2.8 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.4 | 5.5 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 4.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.3 | 4.0 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.3 | 2.5 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.2 | 1.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.2 | 6.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
1.2 | 4.6 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
1.1 | 4.4 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.1 | 3.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
1.0 | 3.1 | GO:0003192 | mitral valve formation(GO:0003192) |
1.0 | 4.1 | GO:0060032 | notochord regression(GO:0060032) |
1.0 | 7.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.0 | 3.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.0 | 2.9 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.0 | 4.8 | GO:0007538 | primary sex determination(GO:0007538) |
1.0 | 2.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.9 | 3.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 2.8 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.9 | 1.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 3.5 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.9 | 3.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.9 | 4.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 2.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.8 | 2.5 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.8 | 3.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 67.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.8 | 3.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 8.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 3.1 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.8 | 0.8 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.8 | 0.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.7 | 2.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.7 | 2.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.7 | 2.2 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.7 | 5.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.7 | 2.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.7 | 3.6 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.7 | 3.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.7 | 2.1 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.7 | 0.7 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.7 | 3.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.7 | 2.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.7 | 3.5 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.7 | 2.7 | GO:0072299 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.7 | 2.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.7 | 3.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.6 | 1.9 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.6 | 5.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 0.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.6 | 3.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.6 | 1.9 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.6 | 0.6 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.6 | 3.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 0.6 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.6 | 1.8 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.6 | 0.6 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.6 | 1.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 1.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 1.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.6 | 5.9 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.6 | 2.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 0.6 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.6 | 0.6 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.6 | 1.7 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.6 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 1.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 1.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.6 | 1.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.6 | 2.8 | GO:0032796 | uropod organization(GO:0032796) |
0.6 | 11.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 1.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.6 | 1.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.6 | 15.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 1.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.6 | 1.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.7 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.6 | 2.2 | GO:0018277 | protein deamination(GO:0018277) |
0.5 | 3.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.5 | 1.6 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.5 | 1.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.5 | 1.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.5 | 2.7 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.5 | 2.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 8.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 5.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 2.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 3.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.6 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.5 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 2.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.5 | 2.1 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.5 | 2.6 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.5 | 1.0 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
0.5 | 4.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 1.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 1.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.5 | 1.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.5 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.5 | 4.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 4.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 6.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.9 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.5 | 2.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 0.5 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.5 | 1.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 1.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.5 | 2.8 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.5 | 4.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.5 | 0.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.5 | 1.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.5 | 2.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 1.8 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) |
0.4 | 2.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.4 | 0.9 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.4 | 1.3 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.4 | 2.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.4 | 1.3 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.4 | 1.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.4 | 1.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.4 | 7.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 3.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.4 | 1.3 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.4 | 1.3 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
0.4 | 5.0 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 1.7 | GO:0006272 | leading strand elongation(GO:0006272) |
0.4 | 3.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 2.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 1.7 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.4 | 4.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 2.5 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.4 | 4.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 0.4 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.4 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 0.8 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.4 | 2.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.4 | 5.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 1.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.4 | 1.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 1.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.4 | 2.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 0.8 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.4 | 2.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.4 | 2.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.4 | 1.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.4 | 2.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 7.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 0.4 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.4 | 1.2 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 1.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.4 | 1.1 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.4 | 4.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 10.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 1.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.4 | 1.1 | GO:0072143 | mesangial cell development(GO:0072143) |
0.4 | 4.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 1.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.8 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.4 | 1.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 1.8 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.4 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 1.5 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.4 | 0.7 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.4 | 2.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.4 | 1.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.4 | 2.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.4 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.4 | 2.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 1.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 2.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.4 | 2.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.8 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.4 | 1.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 0.4 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.4 | 2.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 0.4 | GO:0045401 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.3 | 1.0 | GO:0007351 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 1.0 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 3.4 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 0.7 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) chemorepulsion of dopaminergic neuron axon(GO:0036518) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.3 | 1.7 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.7 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 2.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.7 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.3 | 3.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 1.0 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.3 | 0.7 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.0 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.3 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 2.2 | GO:0001878 | response to yeast(GO:0001878) |
0.3 | 1.0 | GO:0002818 | intracellular defense response(GO:0002818) |
0.3 | 1.0 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 2.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 1.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 0.9 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.3 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.3 | 2.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.9 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.3 | 0.9 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.3 | 0.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.3 | 0.9 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.3 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.3 | 2.5 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.3 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 | 2.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 7.6 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.3 | 0.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.3 | 0.9 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 3.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 0.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.3 | 1.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 2.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 5.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 1.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 3.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 2.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.9 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.3 | 1.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 3.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.9 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.3 | 3.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 0.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 2.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 0.6 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.3 | 0.6 | GO:0042092 | type 2 immune response(GO:0042092) |
0.3 | 1.7 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 5.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.3 | 0.8 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 0.8 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.3 | 1.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 1.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 1.1 | GO:0022009 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.3 | 0.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.3 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 2.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 2.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 2.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.5 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 0.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 1.1 | GO:0052227 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 2.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 1.1 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 8.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 3.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 7.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.3 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.3 | 0.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 0.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.3 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 0.8 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.3 | 3.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 1.0 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.3 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.3 | 2.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 2.8 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 2.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 2.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 2.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 0.5 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.2 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 1.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.2 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 1.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 2.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.7 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.2 | 1.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 1.0 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 4.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.2 | 1.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 | 3.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 27.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.7 | GO:0007369 | gastrulation(GO:0007369) |
0.2 | 5.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.6 | GO:0060026 | convergent extension(GO:0060026) |
0.2 | 3.0 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 1.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.2 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.6 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 1.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 0.7 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.2 | 0.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 1.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.7 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 0.7 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.2 | 2.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 0.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.2 | 1.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 2.6 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.7 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.7 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.2 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.7 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.2 | 0.2 | GO:0060324 | face development(GO:0060324) |
0.2 | 1.1 | GO:0061047 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 2.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.2 | 3.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.6 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 0.6 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.2 | 4.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 35.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.8 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 1.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 1.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.6 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 0.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.2 | 2.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 1.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.8 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.2 | 1.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 2.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 2.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.6 | GO:1904617 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.8 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.2 | 0.2 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.8 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.2 | 2.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.4 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.2 | 3.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 1.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.2 | 1.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 1.0 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 1.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 1.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 1.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 1.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) regulation of female receptivity(GO:0045924) |
0.2 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 7.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 2.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.2 | 0.4 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.2 | 0.8 | GO:1903377 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.9 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 0.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 1.5 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.9 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.2 | 1.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 3.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.7 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 1.8 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.2 | 2.0 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 1.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.5 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 1.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.2 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 2.8 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.2 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.2 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.5 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.5 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.2 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 8.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.2 | 1.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.2 | 3.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 1.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 5.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 2.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 1.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.2 | 2.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.2 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 0.8 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.3 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.3 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.2 | 10.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 1.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 1.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 1.9 | GO:0032963 | collagen metabolic process(GO:0032963) multicellular organismal macromolecule metabolic process(GO:0044259) |
0.2 | 26.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 1.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 2.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.3 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.2 | 0.5 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.2 | 0.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.9 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.2 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) positive regulation of DNA biosynthetic process(GO:2000573) |
0.2 | 1.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) negative regulation of protein depolymerization(GO:1901880) |
0.2 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 0.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.8 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 3.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 1.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 1.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.2 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.8 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 5.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 2.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 8.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 1.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 3.0 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 2.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 1.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.1 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.1 | 0.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 3.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.8 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 1.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 3.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 2.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 5.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 1.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.8 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 6.0 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 1.1 | GO:0045007 | depurination(GO:0045007) |
0.1 | 1.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.3 | GO:1990776 | response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.1 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 1.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.8 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 4.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 2.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 2.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 2.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 5.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 2.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.1 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.1 | GO:1901342 | regulation of vasculature development(GO:1901342) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 2.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 2.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.1 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.1 | 2.0 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.1 | 1.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 4.0 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 14.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.4 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.1 | 5.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 1.2 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 3.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.7 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 3.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.3 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.1 | 0.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 6.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.2 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 1.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 2.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.7 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.9 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.2 | GO:0060631 | meiotic gene conversion(GO:0006311) regulation of meiosis I(GO:0060631) |
0.1 | 1.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.7 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 0.1 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.1 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.1 | 1.4 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.7 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.1 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.6 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.2 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.1 | 0.3 | GO:0071283 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) cellular response to iron(III) ion(GO:0071283) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
0.1 | 1.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 1.7 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.7 | GO:0072677 | eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
0.1 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.5 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.1 | 0.4 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.0 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.2 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 1.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.4 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.1 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.4 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 1.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 2.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 3.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 1.6 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.2 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.1 | 3.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.5 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 1.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.1 | 1.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 2.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 3.4 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 2.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 2.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 5.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 2.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 4.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.1 | 0.9 | GO:0043584 | nose development(GO:0043584) |
0.1 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 1.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.5 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.4 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.3 | GO:2000283 | regulation of arginine metabolic process(GO:0000821) regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.1 | 0.4 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 2.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.0 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.3 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.1 | 0.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.1 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.1 | GO:0035822 | gene conversion(GO:0035822) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 1.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.4 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 1.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 7.8 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 5.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 2.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 5.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.2 | GO:0090238 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 7.4 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 9.2 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 1.1 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.3 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 3.5 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 1.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.8 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 2.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.9 | GO:0048667 | cell morphogenesis involved in neuron differentiation(GO:0048667) |
0.1 | 1.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.5 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.4 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.1 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 1.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.6 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.1 | 0.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 2.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 1.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 2.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 2.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 2.1 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 1.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 2.5 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.7 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 1.8 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.5 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.4 | GO:0072176 | nephric duct development(GO:0072176) |
0.1 | 0.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.7 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 1.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 1.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 1.8 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.5 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.4 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.7 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.2 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.9 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 2.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.1 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.1 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.2 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.1 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 2.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 1.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:0061358 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
0.1 | 15.9 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.7 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.3 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.1 | 0.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 1.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.1 | 0.4 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.9 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.5 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 1.2 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 1.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0031081 | spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.0 | 2.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.3 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.5 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 1.4 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.0 | 4.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 2.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 1.0 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.5 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 1.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.0 | 0.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.0 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.0 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.0 | 0.1 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.0 | 0.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.0 | 0.2 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.3 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.3 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 0.3 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0021503 | neural fold bending(GO:0021503) |
0.0 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.0 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.1 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 1.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 12.2 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.1 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.3 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) negative regulation of viral life cycle(GO:1903901) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.0 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.3 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.2 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.1 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.0 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.0 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.0 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.0 | GO:1904851 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.0 | 0.0 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 1.1 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.1 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.0 | 0.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.8 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.5 | GO:0001501 | skeletal system development(GO:0001501) |
0.0 | 0.6 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.0 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.3 | GO:0050000 | chromosome localization(GO:0050000) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
0.0 | 0.0 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.0 | 0.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.3 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) |
0.0 | 2.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.0 | 0.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.1 | GO:0043379 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0006275 | regulation of DNA replication(GO:0006275) |
0.0 | 0.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.2 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.7 | GO:0031497 | chromatin assembly(GO:0031497) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
1.3 | 14.3 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 5.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.2 | 62.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.1 | 4.4 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 4.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 2.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.9 | 2.7 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.8 | 5.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 3.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.7 | 5.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.6 | 2.5 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
0.6 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.6 | 2.5 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 1.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.6 | 3.0 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.5 | 3.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 4.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.5 | 2.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 1.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 5.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.5 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 3.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 2.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.5 | 0.5 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 2.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 2.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.4 | 4.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 2.6 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 5.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 1.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.4 | 0.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.4 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 2.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.0 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 2.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 3.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 7.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 1.9 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.3 | 3.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 0.9 | GO:0001534 | radial spoke(GO:0001534) |
0.3 | 1.3 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.3 | 2.8 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 2.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.3 | 1.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 0.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 5.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 0.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.3 | 1.2 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 0.9 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.3 | 10.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 3.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 0.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 2.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.9 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.3 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.3 | 1.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.3 | 1.3 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.3 | 0.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 2.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 1.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 3.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.7 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 0.2 | GO:0000806 | Y chromosome(GO:0000806) |
0.2 | 0.2 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) RNA polymerase complex(GO:0030880) |
0.2 | 0.2 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.2 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.9 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.2 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.2 | GO:0005713 | recombination nodule(GO:0005713) |
0.2 | 2.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.7 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.2 | 1.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 15.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.2 | 1.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 4.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 3.6 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 3.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.2 | 2.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 2.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 1.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 1.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 8.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 4.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.6 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.2 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 0.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.4 | GO:0031906 | late endosome lumen(GO:0031906) |
0.2 | 0.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 29.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 5.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.1 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.9 | GO:0070701 | mucus layer(GO:0070701) |
0.2 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.9 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 0.9 | GO:0002133 | polycystin complex(GO:0002133) |
0.2 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 2.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 3.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 23.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 8.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.5 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 19.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 4.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 84.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 3.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.8 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 5.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.6 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 11.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.4 | GO:0002945 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 5.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 2.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 4.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 4.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.3 | GO:0042611 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 1.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 4.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.4 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 2.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 9.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 14.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.8 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.1 | 3.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 2.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 2.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 4.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 2.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) DNA recombinase mediator complex(GO:0033061) |
0.1 | 3.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 0.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.4 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 20.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.7 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 40.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 1.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 17.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 12.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 7.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 0.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.1 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 8.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 2.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 6.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 6.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 7.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 3.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 16.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 5.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 2.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 3.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 3.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 5.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 2.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 7.3 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 2.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 2.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 30.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 1.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 1.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.0 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.0 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.0 | 0.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 6.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 3.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 2.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.3 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 1.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.0 | 1.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.9 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 11.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 23.4 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 1.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.1 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
0.0 | 0.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 3.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 5.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 37.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 2.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 3.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.0 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.3 | GO:0030496 | midbody(GO:0030496) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 13.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.4 | 4.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 6.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.3 | 3.8 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
1.2 | 3.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.1 | 69.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.9 | 2.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.9 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.9 | 2.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 2.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 8.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.8 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.8 | 2.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.7 | 0.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 2.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.7 | 4.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 13.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 3.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 4.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.6 | 0.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.6 | 6.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 5.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.6 | 2.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 0.6 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.5 | 2.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.5 | 2.7 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.5 | 5.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 1.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.5 | 1.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 1.5 | GO:0032093 | SAM domain binding(GO:0032093) |
0.5 | 4.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 3.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 7.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 1.4 | GO:0030395 | lactose binding(GO:0030395) |
0.5 | 11.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 1.4 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.5 | 1.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 14.7 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 2.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 2.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.5 | 2.8 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.5 | 3.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.4 | 4.5 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 5.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.4 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.4 | 2.0 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 2.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 1.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.4 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 1.2 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.4 | 2.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 2.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 1.1 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.4 | 2.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 7.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 5.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 1.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.4 | 1.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.4 | 4.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.1 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.4 | 12.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 78.3 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 1.1 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.4 | 1.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.4 | 7.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 3.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.3 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 2.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 3.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 14.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 3.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.3 | 4.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 6.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 0.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 1.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.3 | 0.9 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.3 | 0.9 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 6.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 2.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.3 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.9 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.3 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.3 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 1.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.3 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 1.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.3 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.3 | 0.9 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.3 | 6.2 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.3 | 0.8 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.3 | 3.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 2.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 9.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 1.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 0.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.3 | 5.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 0.8 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.3 | 1.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 2.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 1.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.3 | 1.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 0.8 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 11.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.3 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.2 | 4.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 3.7 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 2.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 1.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 28.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.9 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 7.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.9 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 0.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 0.9 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 0.2 | GO:0008410 | 3-oxoacid CoA-transferase activity(GO:0008260) CoA-transferase activity(GO:0008410) |
0.2 | 1.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 3.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.9 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 1.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 3.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 1.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 10.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 6.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 1.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.6 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.2 | 2.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.8 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.2 | 1.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.2 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.6 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 3.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 2.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.2 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.2 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
0.2 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.0 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 1.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 3.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 2.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 3.0 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 2.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 8.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.2 | 1.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 5.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 3.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 0.2 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 5.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 4.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 3.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 2.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 6.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 2.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 5.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 4.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 5.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 1.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.6 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.2 | 15.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 19.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 6.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 2.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.4 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 1.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 3.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 2.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 2.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.1 | 3.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 0.4 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.1 | 2.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 8.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 3.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 3.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 2.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 21.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 1.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.7 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.1 | 19.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.3 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 3.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 3.7 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.7 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.1 | 2.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 5.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 1.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.6 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 2.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 2.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 12.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 0.6 | GO:0045118 | azole transporter activity(GO:0045118) |
0.1 | 0.8 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 1.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 3.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 5.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.4 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.1 | GO:0015166 | myo-inositol transmembrane transporter activity(GO:0005365) polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 16.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 2.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 6.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.4 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 2.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.6 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
0.1 | 14.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 1.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 4.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 3.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 102.5 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 2.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 7.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 1.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 15.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 3.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.2 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 1.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.2 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.7 | GO:0030674 | protein binding, bridging(GO:0030674) binding, bridging(GO:0060090) |
0.0 | 1.8 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.2 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.0 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 1.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 2.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 3.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 1.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 1.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.0 | 0.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.3 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 1.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 8.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.0 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0048531 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.0 | 1.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 2.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 1.2 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 5.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.2 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
0.0 | 0.1 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.0 | 0.1 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 1.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.2 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 14.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.0 | 0.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.1 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 3.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 30.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 20.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 6.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 99.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 40.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 19.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 7.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 2.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 5.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 5.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 4.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 6.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 25.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 12.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 5.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 6.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 15.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 6.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 19.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 8.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 14.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 6.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 7.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 19.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 6.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 4.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 8.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 3.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 17.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 5.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 8.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 2.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 7.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 3.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 3.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 5.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 15.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 13.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 4.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 38.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 4.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 8.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 5.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 3.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 4.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 17.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 2.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 5.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 8.6 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 2.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 0.9 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.4 | 5.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 17.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 14.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 2.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 2.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 23.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 6.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 8.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 1.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 13.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.7 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 2.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 11.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 6.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 17.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 33.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 7.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 3.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 13.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 3.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 7.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 6.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 8.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 5.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 19.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 5.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 5.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 2.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 5.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 1.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 3.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 3.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 12.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 7.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 8.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 5.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 6.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 5.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 8.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 5.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 3.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 3.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 7.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 6.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 2.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 10.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 14.8 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 6.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 6.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 16.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 4.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 1.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 6.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 3.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 15.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 2.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.5 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.0 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 3.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 6.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 2.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |